Portola Pharmaceuticals, Inc. (PTLA)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 5.31 / 29.72
Exchange NASDAQ
Div & Yield N.A. (N.A)
5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

4 Possible Acquisition Targets in Biotech

4 Possible Acquisition Targets in Biotech

These mid-caps would do well by themselves, but could tempt bigger companies.

Takeaways and Observations

I was out of the office yesterday, but my take on the session is: "Up, Down, Up, Flat." It was a mixed day in terms of economic data, with potholes everywhere. (You'd have to be blind not to see them.) It was all about retail yet again, and it sure ...

My Takeaways and Observations

I started the day with an updated and still ursine market update: "Hey, Let's Be Careful Out There."   A new investment short -- England, via iShares MSCI United Kingdom (EWU).  EWU as a short went on my Best Ideas List. Jim Chanos and I are thinkin...

My Takeaways and Observations

Today and yesterday are good examples of the fondness of crowds, and that buyers live higher and sellers live lower. Stocks closed at the day's highs, despite a reversal in the price of crude oil and some weak domestic data and disappointing retail ...

My Takeaways and Observations

Another strong market day.  The issue of taxes was front and center today. Here are some of my takes: My Take on Corporate Taxes  Man Up, Allergan Shareholders  Who Loses in Pfizer/Allergan Deal's Demise?  I remain manifestly bearish, in the belief ...

Today's Takeaways and Observations (Early Edition)

I started the day today by dissing the banks.                  Then, I unfriended Facebook (FB) by making it my Short Trade of the Week. Finally, I offered another critical post about auto stocks. Hey, at least I'm consistent! And at least I like Op...

Biotech Biowreck!

The collapse of Valeant Pharmaceuticals (VRX) has cast a pall over the entire biotech sector today. The iShares Nasdaq Biotechnology ETF (IBB) is down by about 3%, led by VRX plus significant drops in Allergan (AGN), Celgene (CELG) and Gilead Scienc...

My Takeaways and Observations

 "What came first? The chicken or the Ben?" --Tiara Soleim, talking about "The Bachelor's" Ben Higgins this season Final rose? The obvious and recurrence of price action from the past continues, but for how long? Maybe only The Shadow knows.  "Move ...

My Takeaways and Observations

I remain "all in short," positioned on Friday afternoon.   My message for the day this morning? "Don't worship at the church of what's happening now."  The key insight today was the flight to safety. More risk off might lie ahead. Thanks for the nic...

My Takeaways and Observations

What a weekend at the First Annual RealMoneyPro Golf Tournament and Conference! Unprecedented fun!!  Here is why I am "all in" short.  I made some important portfolio changes today, selling six core long investments.  I am at my largest net short po...

My Takeaways and Observations

A win for the bulls. I outlined my cautious view in my opener.  I sold a number of longs and reduced my long side today.   I sold my biotech basket for a good two-and-a-half-week gain.  I reduced my bank longs from large to between small and medium ...

Selling Biotechs for Some Nice Gains

I'm reducing the size of my biotech basket by selling across the board following some very large gains. In fact, I expect to completely eliminate my holdings if we see any further increases. Today's gains have been truly breathtaking. We've seen 5% ...

Biotech Goes From Goat to Hero

Several members in my new biotech basket have continued to make notable upside moves throughout the recent rally, including today. Winners include Acadia Pharmaceuticals (ACAD), Aerie Pharmaceuticals (AERI), Cempra (CEMP), Intrexon (XON), Portola Ph...

My Takeaways and Observations

If I had to guess, today's sharp rally was a function of monthly inflows, technical breakouts and programs. But it is only a guess. However, you will watch in the business media all the talking heads who liked yesterday's market and purchased opport...

My Takeaways and Observations

Another volatile today that was oil price-centric. A 265-point intraday DJIA move, 30+ handles on the S&P and a 10-basis-point move in the 10-year U.S. note yield. A yawner! Classic rally from the lows, led by a reversal in crude oil, lower bond pri...

My Takeaways and Observations

Mr. Market has provided outstanding opportunities year to date. I am happy with the way I have been trading the market, taking advantage of the market without memory from day to day and staying with my game plan in an unemotional way. The banks -- e...

Takeaways and Observations

Hello, all -- I'm back! Great job yesterday by Chris "Not the Designer" Versace in subbing for me. My takeaways and observations regarding yesterday's action: St. Louis Fed President James Bullard is full of bull. Ray Dalio of hedge fund Bridgewater...

My Takeaways and Observations

This might be the most hated market rally in months.  As I have been commenting, we got deeply oversold, support held and machines/algos did the rest! The typical correlation between SPDR S&P 500 ETF (SPY) and the inverse iShares 20+ Year Treasury B...

Today's Takeaways and Observations

Chuck (Judge Smails) thoroughly embarrassed me into making a day's end post, noting that when I was younger I had the energy to still complete Takeaways. He went on to write that my current age is slowing me down. I know (hope!) you were kidding and...

Buying Biotechs

The iShares Nasdaq Biotechnology ETF (IBB) has tumbled from nearly $400 a share early last summer to around $240 at last check, so I'm taking advantage of today's market schmeissing to purchase a small position in a biotech (biowreck?). I'm buying a...